Vitamin D-Related Parameters and Th17 Pathway in Multiple Sclerosis: A Serological, Transcriptomic and Functional Study

S Feki, YB Ali, R Fakhfakh, S Sakka, O Abida… - Multiple Sclerosis and …, 2023 - Elsevier
Introduction A combination of genetic, environmental, and immunologic factors contributes to
the development of Multiple sclerosis (MS) disease. The IL23/Th17 pathway seems to play …

Vitamin D supplementation up-regulates IL-6 and IL-17A gene expression in multiple sclerosis patients

BN Gargari, M Behmanesh, ZS Farsani… - International …, 2015 - Elsevier
Vitamin D regulates gene expression and affects target cell functions. IL-6 and IL-17A are
pro-inflammatory cytokines associated with MS pathogenesis. The aim of this study was to …

Vitamin D modulates different IL-17-secreting T cell subsets in multiple sclerosis patients

DSMM da Costa, J Hygino, TB Ferreira… - Journal of …, 2016 - Elsevier
Vitamin D deficiency is an environmental risk factor for MS, a Th17 cell-mediated
autoimmune disease that results in demyelination in the CNS. Therefore, we aimed to …

[HTML][HTML] The impact of vitamin D3 intake on inflammatory markers in multiple sclerosis patients and their first-degree relatives

R Hashemi, SS Hosseini-Asl, SR Arefhosseini… - PloS one, 2020 - journals.plos.org
Background & aims In our previous study, a Seesaw model was proposed for the fluctuation
of crucial anti-(IL-10) and pro-inflammatory (Il-6 & IL-17A) cytokines through vitamin D3. In …

Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial

N Toghianifar, F Ashtari, SH Zarkesh-Esfahani… - Journal of …, 2015 - Elsevier
Background Vitamin D has immunomodulatory effects in multiple sclerosis (MS). Vitamin D
acts through various mechanisms such as secretion of cytokines. Interleukin-17 (IL-17) is a …

Anti-inflammatory effects of dietary vitamin D3 in patients with multiple sclerosis

R Hashemi, M Morshedi, M Asghari Jafarabadi… - Neurology …, 2018 - AAN Enterprises
Objective To assess the effects of dietary vitamin D3 on proinflammatory (interleukin-17A [IL-
17A] and IL-6) and anti-inflammatory (IL-10) cytokines. Methods Our study was conducted …

[HTML][HTML] Vitamin D deficiency in relation with the systemic and central inflammation during multiple sclerosis

S Feki, M Naifar, M Dammak, S Majdoub… - Journal of Medical …, 2023 - ncbi.nlm.nih.gov
Background During the last decade, vitamin D (VitD) has become a topic of interest in
immune regulation, especially in multiple sclerosis (MS) disease. Amongst the wide range of …

[HTML][HTML] Can Vitamin D Reduce Inflammation? The Influence of Supplementation on Selected Immunological Markers

M Lis, N Niedziela, J Adamczyk-Zostawa… - International Journal of …, 2024 - mdpi.com
There is increasing evidence that vitamin D (VitD) supplementation may reduce
inflammation in individuals with multiple sclerosis (MS). The aim of this study was to …

[HTML][HTML] The impact of vitamin D low doses on its serum level and cytokine profile in multiple sclerosis patients

A Walawska-Hrycek, W Galus, E Hrycek… - Journal of Clinical …, 2021 - mdpi.com
Vitamin D is known to have immunomodulatory properties and its deficiency is identified as
an environmental risk factor for the development of autoimmune diseases, including multiple …

Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients

ZS Farsani, M Behmanesh, MA Sahraian - Journal of the Neurological …, 2015 - Elsevier
Multiple sclerosis (MS) is an inflammatory and autoimmune disease. Variety of different
genetics and environmental factors are involved in MS pathology. The epidemiological …